Anna Krasnianski

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial

Gabriella Marcon, Alain Mallet, Mauro Tettamanti et al. · The Lancet Neurology · 2014 · 200 citations

Creutzfeldt-jakob Disease, Medicine, Placebo-controlled Trial +4

Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance

Uta Heinemann, Anna Krasnianski, Daniela Varges et al. · Brain · 2007 · 196 citations · Full text

Quantitative Analysis of Transthyretin, Tau and Amyloid-β in Patients with Dementia

Sara Friederike Gloeckner, Felix Meyne, Fabian Wagner et al. · Journal of Alzheimer s Disease · 2008 · 117 citations

Neurochemical Biomarkers, Tau Protein Levels, Alzheimer's Disease +18

Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD

Anna Krasnianski · Brain · 2006 · 110 citations · Full text

Doxycycline in early CJD: a double-blinded randomised phase II and observational study

Daniela Varges, H. G. Manthey, Uta Heinemann et al. · Journal of Neurology Neurosurgery & Psychiatry · 2016 · 102 citations · Full text